Session 15
Thursday, 26 September 2024 | 09:00-10:00 | Conference Centre
The AI Act is now a reality - it’s showtime and its implementation begins! The EU AI Act represents a significant milestone and global precedence in AI ethics and governance. But what does it mean for the patients, clinicians, and industry? To ensure a smooth uptake and adherence, collaborative and transparent communication among all stakeholders will be key to positively harnessing AI’s potential.
How is the healthcare sector preparing and where is special attention and common effort needed? What are the lessons from other health regulations, such as the new Medical Devices Regulation (MDR) and the In Vitro Diagnostic Medical Devices Regulation (IVDR), and how will the AI Act interact with them? The panel will discuss the critical aspects of the AI Act, including product quality and innovation, safety, and patient rights.